Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportODT: Early Phase (Phase 0 or I) human studies

Glucagon-like peptide-1 receptor PET/CT with 68Ga-Exendin-4 for localizing insulinoma: a real-world, single-center study

Hongzhe Zhang, Qingqing Pan, Silu Liu, Jie Feng and Yaping Luo
Journal of Nuclear Medicine June 2025, 66 (supplement 1) 251688;
Hongzhe Zhang
1chinese academy of medical sciences and peking union medical college hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qingqing Pan
2peking union medical college hospital,beijing china
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silu Liu
3department of nuclear medicine, peking union medical college hospital, chinese academy of medical sciences and peking union medical college, beijing, china
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie Feng
3department of nuclear medicine, peking union medical college hospital, chinese academy of medical sciences and peking union medical college, beijing, china
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaping Luo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 66, Issue supplement 1
June 1, 2025
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Glucagon-like peptide-1 receptor PET/CT with 68Ga-Exendin-4 for localizing insulinoma: a real-world, single-center study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Glucagon-like peptide-1 receptor PET/CT with 68Ga-Exendin-4 for localizing insulinoma: a real-world, single-center study
Hongzhe Zhang, Qingqing Pan, Silu Liu, Jie Feng, Yaping Luo
Journal of Nuclear Medicine Jun 2025, 66 (supplement 1) 251688;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Glucagon-like peptide-1 receptor PET/CT with 68Ga-Exendin-4 for localizing insulinoma: a real-world, single-center study
Hongzhe Zhang, Qingqing Pan, Silu Liu, Jie Feng, Yaping Luo
Journal of Nuclear Medicine Jun 2025, 66 (supplement 1) 251688;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 68Ga-NK224 PET/CT for Non-Invasive Evaluation of PD-L1 Expression and Inter-Tumor Heterogeneity: A Translational Exploratory Study
  • First Clinical Evaluation of 68Ga-LNTH-1363S, a Novel FAP-Targeting Radiopharmaceutical for PET Imaging: Physiological Biodistribution and Tumor Uptake in Cancer Patients
  • PET Intra-Patient Inter-Lesion Radiomics Feature Aggregation to Enhance PRRT Progression Predictions in Patients with Neuroendocrine Tumors
Show more ODT: Early Phase (Phase 0 or I) human studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire